← Eichor
Condition: Extramammary Paget Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Extramammary Paget Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05859074
A Study on the Efficacy of Disitamab Vedotin in Advanced HER2-positive Paget's Disease.
Phase 2 · 1 location(s) · Fudan University · NCT06561555
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 · 1 location(s) · Fudan University · NCT06683846
A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum
Phase 2 · 1 location(s) · Fujian Medical University Union Hospital · NCT06791070
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06873815
A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease
Phase 2 · 1 location(s) · Fudan University · NCT07117851
Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies
Phase 2 · 1 location(s) · Sheng Zhang · NCT07309770
Gynecologic Extramammary Paget's Disease
Phase N/A · 1 location(s) · Mayo Clinic · NCT03564483
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanc
Phase 2 · 1 location(s) · Fudan University · NCT06684327
PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).
NA · 1 location(s) · University Hospital, Lille · NCT03713203
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.